These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37852801)

  • 1. [Cost of high-throughput sequencing (NGS) technologies: Literature review and insights].
    Bayle A; Marino P; Baffert S; Margier J; Bonastre J
    Bull Cancer; 2024 Feb; 111(2):190-198. PubMed ID: 37852801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study.
    Marino P; Touzani R; Perrier L; Rouleau E; Kossi DS; Zhaomin Z; Charrier N; Goardon N; Preudhomme C; Durand-Zaleski I; Borget I; Baffert S;
    Eur J Hum Genet; 2018 Mar; 26(3):314-323. PubMed ID: 29367707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs of Next-Generation Sequencing Assays in Non-Small Cell Lung Cancer: A Micro-Costing Study.
    Kumar S; Bennett A; Campbell PA; Palidwor G; Lo B; Perkins TJ; Nochaiwong S; Sekhon HS; Stewart DJ; Thavorn K
    Curr Oncol; 2022 Jul; 29(8):5238-5246. PubMed ID: 35892985
    [No Abstract]   [Full Text] [Related]  

  • 4. Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting.
    Bayle A; Droin N; Besse B; Zou Z; Boursin Y; Rissel S; Solary E; Lacroix L; Rouleau E; Borget I; Bonastre J
    Eur J Health Econ; 2021 Aug; 22(6):855-864. PubMed ID: 33765190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-minimization analysis of sequential genetic testing versus targeted next-generation sequencing gene panels in patients with pheochromocytoma and paraganglioma.
    Pipitprapat W; Pattanaprateep O; Iemwimangsa N; Sensorn I; Panthan B; Jiaranai P; Chantratita W; Sorapipatcharoen K; Poomthavorn P; Mahachoklertwattana P; Sura T; Tunteeratum A; Srichan K; Sriphrapradang C
    Ann Med; 2021 Dec; 53(1):1243-1255. PubMed ID: 34309460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of exome analysis in patients with intellectual disability: a micro-costing study in a French setting.
    Soilly AL; Robert-Viard C; Besse C; Bruel AL; Gerard B; Boland A; Piton A; Duffourd Y; Muller J; Poë C; Jouan T; El Doueiri S; Faivre L; Bacq-Daian D; Isidor B; Genevieve D; Odent S; Philip N; Doco-Fenzy M; Lacombe D; Asensio ML; Deleuze JF; Binquet C; ; Thauvin-Robinet C; Lejeune C
    BMC Health Serv Res; 2023 Apr; 23(1):386. PubMed ID: 37085862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of next-generation sequencing techniques in diagnosis of genetic disorders: A systematic review.
    Rezapour A; Souresrafil A; Barzegar M; Sheikhy-Chaman M; Tatarpour P
    Clin Genet; 2023 May; 103(5):513-528. PubMed ID: 36808726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Next Generation Sequencing (NGS) for beginners].
    Georget M; Pisan E
    Rev Mal Respir; 2023 Apr; 40(4):345-358. PubMed ID: 36863993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the $1000 Genome as Near as We Think? A Cost Analysis of Next-Generation Sequencing.
    van Nimwegen KJ; van Soest RA; Veltman JA; Nelen MR; van der Wilt GJ; Vissers LE; Grutters JP
    Clin Chem; 2016 Nov; 62(11):1458-1464. PubMed ID: 27630156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of high-throughput next-generation sequencing technology in clinical laboratory diagnosis of infectious diseases].
    Wang CB
    Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(15):1087-1091. PubMed ID: 37055226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximizing the potential of high-throughput next-generation sequencing through precise normalization based on read count distribution.
    Brennan C; Salido RA; Belda-Ferre P; Bryant M; Cowart C; Tiu MD; González A; McDonald D; Tribelhorn C; Zarrinpar A; Knight R
    mSystems; 2023 Aug; 8(4):e0000623. PubMed ID: 37350611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequencing technologies and genome sequencing.
    Pareek CS; Smoczynski R; Tretyn A
    J Appl Genet; 2011 Nov; 52(4):413-35. PubMed ID: 21698376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-Generation Sequencing vs Culture-Based Methods for Diagnosing Periprosthetic Joint Infection After Total Knee Arthroplasty: A Cost-Effectiveness Analysis.
    Torchia MT; Austin DC; Kunkel ST; Dwyer KW; Moschetti WE
    J Arthroplasty; 2019 Jul; 34(7):1333-1341. PubMed ID: 31005439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of Plant Productivity in the Post-Genomics Era.
    Thao NP; Tran LS
    Curr Genomics; 2016 Aug; 17(4):295-6. PubMed ID: 27499678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next-Generation Sequencing: An Emerging Tool for Drug Designing.
    Tripathi P; Singh J; Lal JA; Tripathi V
    Curr Pharm Des; 2019; 25(31):3350-3357. PubMed ID: 31544713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the next-generation sequencing data depth on various biological result inferences.
    Hou R; Yang Z; Li M; Xiao H
    Sci China Life Sci; 2013 Feb; 56(2):104-9. PubMed ID: 23393025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review of Health Economic Studies Comparing Traditional and Massively Parallel Sequencing Diagnostic Pathways for Suspected Genetic Disorders.
    Fahr P; Buchanan J; Wordsworth S
    Pharmacoeconomics; 2020 Feb; 38(2):143-158. PubMed ID: 31741314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation.
    Colman RE; Mace A; Seifert M; Hetzel J; Mshaiel H; Suresh A; Lemmer D; Engelthaler DM; Catanzaro DG; Young AG; Denkinger CM; Rodwell TC
    PLoS Med; 2019 Apr; 16(4):e1002794. PubMed ID: 31039166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using "Big Data" in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies: Challenges and Potential Solutions.
    Wordsworth S; Doble B; Payne K; Buchanan J; Marshall DA; McCabe C; Regier DA
    Value Health; 2018 Sep; 21(9):1048-1053. PubMed ID: 30224108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A general framework for classifying costing methods for economic evaluation of health care.
    Špacírová Z; Epstein D; García-Mochón L; Rovira J; Olry de Labry Lima A; Espín J
    Eur J Health Econ; 2020 Jun; 21(4):529-542. PubMed ID: 31960181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.